Table 1 Ultrasonography and CMR parameters.

From: The Association between Diffuse Myocardial Fibrosis on Cardiac Magnetic Resonance T1 Mapping and Myocardial Dysfunction in Diabetic Rabbits

 

DM group

Control group

Baseline

3 months

6 months

9 months

Baseline

3 months

6 months

9 months

LA (mm)

9.56 ± 0.98

10.56 ± 0.58

9.97 ± 0.86

11.36 ± 0.82

9.95 ± 0.68

9.79 ± 0.81

10.61 ± 0.58

11.56 ± 0.67

IVS (mm)

2.32 ± 0.41

2.43 ± 0.32

2.42 ± 0.51

2.52 ± 0.62

2.63 ± 0.24

2.34 ± 0.32

2.75 ± 0.31

2.86 ± 0.63

LVPW (mm)

2.33 ± 0.51

2.56 ± 0.32

2.78 ± 0.67

2.89 ± 0.43

2.35 ± 0.19

2.67 ± 0.41

2.78 ± 0.53

2.89 ± 0.67

LVIDd (mm)

15.67 ± 0.59

16.67 ± 0.81

16.65 ± 0.78

17.67 ± 0.55

14.75 ± 0.87

15.68 ± 0.85

16.64 ± 0.54

16.98 ± 0.67

LVIDs (mm)

11.67 ± 1.21

12.87 ± 1.16

12.45 ± 1.13

12.67 ± 1.41

11.78 ± 1.32

11.97 ± 1.21

13.67 ± 1.29

12.67 ± 1.26

EF (%)

60.33 ± 4.51

61.33 ± 4.23

62.33 ± 3.57

62.67 ± 4.53

61.53 ± 4.23

63.33 ± 5.51

63.73 ± 4.35

62.37 ± 4.54

FS (%)

31.33 ± 3.16

32.33 ± 3.23

32.78 ± 3.45

34.33 ± 3.32

30.67 ± 3.15

31.54 ± 3.24

35.33 ± 4.51

34.33 ± 3.36

SR

18.63 ± 1.25

18.06 ± 1.50

18.83 ± 1.42

14.33 ± 1.60*

18.46 ± 1.37

18.54 ± 1.60

18.71 ± 1.33

18.35 ± 1.14*

SrR

−8.24 ± 0.64

−8.33 ± 0.53

−6.60 ± 1.17*

−5.01 ± 1.11*

−8.19 ± 0.72

−8.26 ± 0.42

−8.11 ± 1.01*

−8.16 ± 0.60*

ECV

29.96 ± 1.33

32.31 ± 1.54*

35.82 ± 1.41*

39.81 ± 1.63*

30.01 ± 1.21

30.05 ± 1.59*

29.83 ± 1.47*

30.33 ± 1.75*

  1. *p < 0.05 vs. the control group at the same time point.